207 related articles for article (PubMed ID: 38408066)
1. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L; Zucker DM; Akriv A; Cucchiara S; Cameron FL; Wilson DC; Lazowska I; Yianni L; Paul SP; Romano C; Kolacek S; Buderus S; Pærregaard A; Russell RK; Escher JC; Turner D;
J Crohns Colitis; 2017 Sep; 11(9):1078-1084. PubMed ID: 28430891
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of inflammatory bowel disease unclassified: a case-control study.
Shao Y; Zhao Y; Lv H; Yan P; Yang H; Li J; Li J; Qian J
BMC Gastroenterol; 2024 Mar; 24(1):105. PubMed ID: 38481157
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.
D'Arcangelo G; Aloi M
Paediatr Drugs; 2017 Apr; 19(2):113-120. PubMed ID: 28150131
[TBL] [Abstract][Full Text] [Related]
5. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
Burisch J; Zammit SC; Ellul P; Turcan S; Duricova D; Bortlik M; Andersen KW; Andersen V; Kaimakliotis IP; Fumery M; Gower-Rousseau C; Girardin G; Valpiani D; Goldis A; Brinar M; Čuković-Čavka S; Oksanen P; Collin P; Barros L; Magro F; Misra R; Arebi N; Eriksson C; Halfvarson J; Kievit HAL; Pedersen N; Kjeldsen J; Myers S; Sebastian S; Katsanos KH; Christodoulou DK; Midjord J; Nielsen KR; Kiudelis G; Kupcinskas L; Nikulina I; Belousova E; Schwartz D; Odes S; Salupere R; Carmona A; Pineda JR; Vegh Z; Lakatos PL; Langholz E; Munkholm P;
J Gastroenterol Hepatol; 2019 Jun; 34(6):996-1003. PubMed ID: 30562421
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study.
Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv Å; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirström G; Sandstedt B
Scand J Gastroenterol; 2012 Feb; 47(2):162-9. PubMed ID: 22229803
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
9. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L; Wilson DC; Kolho KL; Karolewska-Bochenek K; Afzal NA; Spray C; Romano C; Lionetti P; Hauer AC; Martinez-Vinson C; Veres G; Escher JC; Turner D;
Inflamm Bowel Dis; 2016 Aug; 22(8):1908-14. PubMed ID: 27135480
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
11. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
Aloi M; Birimberg-Schwartz L; Buderus S; Hojsak I; Fell JM; Bronsky J; Veereman G; Koletzko S; Shaoul R; Miele E; Turner D; Russell RK
Inflamm Bowel Dis; 2016 Jun; 22(6):1378-83. PubMed ID: 27135479
[TBL] [Abstract][Full Text] [Related]
12. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
[TBL] [Abstract][Full Text] [Related]
13. SYSTEMATIC REVIEW AND META - ANALYSIS OF THE FREQUENCY AND RE-CLASSIFICATION TRENDS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE - UNCLASSIFIED.
Bolia R; Goel AD
Arq Gastroenterol; 2022; 59(4):531-539. PubMed ID: 36515348
[TBL] [Abstract][Full Text] [Related]
14. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
15. De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry.
Zaghiyan K; Kamiński JP; Barmparas G; Fleshner P
Am Surg; 2016 Oct; 82(10):977-981. PubMed ID: 27779987
[TBL] [Abstract][Full Text] [Related]
16. Postoperative diagnostic revision for Crohn disease after subtotal colectomy for inflammatory bowel disease.
Hermand H; Lefèvre JH; Shields C; Chafai N; Debove C; Beaugerie L; Svrcek M; Parc Y;
Int J Colorectal Dis; 2021 Apr; 36(4):709-715. PubMed ID: 33084950
[TBL] [Abstract][Full Text] [Related]
17. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
Ye YL; Pang Z; Gu W; Zheng JJ
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
[No Abstract] [Full Text] [Related]
18. The natural history of pediatric-onset IBD-unclassified and prediction of Crohn's disease reclassification: a 27-year study.
Rinawi F; Assa A; Eliakim R; Mozer-Glassberg Y; Nachmias Friedler V; Niv Y; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Scand J Gastroenterol; 2017 May; 52(5):558-563. PubMed ID: 28128677
[TBL] [Abstract][Full Text] [Related]
19. High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region.
Flanagan A; Allsopp SM; O'Connor SA; Tobin J; Pretorius C; Brown IS; Bell S; Daveson AJM
Intern Med J; 2023 Sep; 53(9):1602-1609. PubMed ID: 36579712
[TBL] [Abstract][Full Text] [Related]
20. Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area.
Hernández V; de Castro ML; Salinas-Rojo M; Fernández A; Martínez-Ares D; Sanromán L; Pineda JR; Carmona A; Salgado-Álvarez C; Martínez-Cadilla J; Pereira S; García-Burriel JI; González-Portela C; Vázquez S; Rodríguez-Prada JI;
Rev Esp Enferm Dig; 2022 Feb; 114(2):103-106. PubMed ID: 34154368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
